Privacy Policy: Research Review will record your email details on a secure database and will not release them to anyone without your prior approval. Research Review and you have the right to inspect, update or delete your details at any time. The views expressed in this Publication are personal to the authors, and do not necessarily represent the views or policy of the Ministry of Health on the issues dealt with in the publication.
Disclaimer: This publication is not intended as a replacement for regular medical education but to assist in the process. The reviews are a summarised interpretation of the published study and reflect the opinion of the writer rather than those of the research group or scientific journal. It is suggested readers review the full trial data before forming a final conclusion on its merits.
Research Review publications are intended for New Zealand health professionals.
Smoking prevalence among doctors and nurses— 2013 New Zealand census data
Authors: Edwards R et al.
Summary: The 2013 New Zealand Census included 7,065 male and 5,619 female doctors, and 2,988 male
and 36,138 female nurses; 2% of male and female doctors and 9% of male and 8% of female nurses were
regular cigarette smokers. Corresponding rates in the 2006 Census were all higher: 4% of male and 3% of
female doctors were regular cigarette smokers, as were 20% of male and 13% of female nurses. In the 2013
Census, psychiatric nurses had the highest smoking prevalence (15% male, 18% female). Smoking was more
common among Māori doctors (6.8%) and nurses (19.3%). Around 96% of young (<25 years) doctors and 87%
of young nurses had never been regular smokers.
Reference: N Z Med J. 2018;131(1471):48-57
Abstract
Impact of five tobacco endgame strategies on future smoking prevalence, population health and health system costs: two modelling studies to inform the tobacco endgame
Authors: van der Deen FS et al.
Summary: Using the NZ Smokefree goal for 2025 as a case study, these researchers modelled the impacts
on smoking prevalence, health gains (quality-adjusted life-years [QALYs]) and cost savings of (1) 10% annual
tobacco tax increases, (2) a tobacco-free generation, (3) a substantial outlet reduction strategy, (4) a sinking
lid on tobacco supply and (5) a combination of 1, 2 and 3. The analysis included two models: (1) a dynamic
population forecasting model for smoking prevalence and (2) a closed cohort (population alive in 2011)
multistate life table model (including 16 tobacco-related diseases) for health gains and costs. All selected
tobacco endgame strategies were associated with reductions in smoking prevalence by 2025, down from
34.7%/14.1% for Māori/non-Māori in 2011 to 16.0%/6.8% for tax increases; 11.2%/5.6% for the tobaccofree
generation; 17.8%/7.3% for the outlet reduction; 0% for the sinking lid; and 9.3%/4.8% for the combined
strategy. Major health gains accrued over the remainder of the 2011 population’s lives ranged from 28,900
QALYs (95% Uncertainty Interval [UI] 16,500 to 48,200; outlet reduction) to 282,000 QALYs (95% UI 189,000
to 405,000; sinking lid) compared with business-as-usual (3% discounting). The timing of health gain and cost
savings greatly differed for the various strategies (with accumulated health gain peaking in 2040 for the sinking
lid and 2070 for the tobacco-free generation).
Reference: Tobacco Control. 2018;27:278-86
Abstract